A Study of Mutant Selective-Inhibitor (CGT6297), in Patients With Advanced Solid Tumors
Cogent Biosciences, Inc.
Cogent Biosciences, Inc.
Convalife (Shanghai) Co., Ltd.
Kaiser Permanente
Second Life Therapeutics
Universidade Federal de Pernambuco
Danatlas Pharmaceuticals Co., Ltd
NovaOnco Therapeutics Co., Ltd.
Sun Yat-sen University
Convalife (Shanghai) Co., Ltd.